Law Firm Investigates Corporate Deals, Urges Shareholders to Act
Monteverde & Associates PC announced investigations into four corporate deals involving Cross Country Healthcare, Equitable Holdings, Axalta Coating Systems, and Citizens National Corporation. The firm is advising shareholders to review their positions before upcoming votes.
NEW YORK, NY – July 14, 2026 – The law firm Monteverde & Associates PC announced today that it has initiated investigations into several corporate transactions where shareholder interests may have been compromised. The firm, specializing in M&A-related class actions, has urged shareholders of the involved companies to assess their situations prior to upcoming shareholder votes.
The transactions under scrutiny include the sale of Cross Country Healthcare (NASDAQ: CCRN) to KL Criss Cross Intermediate, LLC, with shareholders expected to receive $13.25 per share. Also being examined is Equitable Holdings' (NYSE: EQH) merger with Corebridge Financial, where Equitable shareholders will own approximately 49% of the combined entity. Axalta Coating Systems (NYSE: AXTA), being sold to Akzo Nobel N.V. in a stock-for-stock deal, and Citizens National Corporation (OTCID: CZNL), to be acquired by Peoples Bancorp, Inc. for a mix of stock and cash, are also part of the investigation.
While the firm's announcement does not state specific allegations of wrongdoing, the call to action before shareholder votes suggests a potential concern that the terms of these deals may not be fully favorable to shareholders. In mergers and acquisitions requiring shareholder approval, management typically presents proposals deemed in the best interest of the company, but legal oversight is aimed at ensuring all shareholder rights are protected.
Monteverde & Associates PC has a history of recovering substantial sums for shareholders and is recognized for its securities litigation practice. The firm, operating from the Empire State Building, has stated that "no company, director or officer is above the law." This statement may indicate that the firm is seeking evidence of potential breaches of fiduciary duty by company leadership or inadequacy in the proposed transaction terms.
Shareholders with concerns or those seeking additional information are encouraged to contact the firm for a no-cost, no-obligation consultation. The shareholder votes are scheduled throughout July and early August 2026, creating a critical window for any interested parties to engage.